Dan Murphy

Dan Murphy is a government relations, public health, advocacy, and public policy professional specializing in the biotech and pharmaceutical sectors, currently leading Gilead’s global HIV policy and government affairs strategy. With a diverse background that includes positions such as Board Member for the European Federation of Allergies and Airways Diseases and Senior Government Relations Adviser at the Greater London Authority, Dan has built extensive expertise in consensus-building, strategic partnerships, and public affairs. They have worked with governments and institutions across multiple regions, including the UK, Europe, and North America, and have earned recognition for transforming healthcare policies and driving investments in health research. Dan holds a Master’s degree in Public Policy and Government from Brunel University.